Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Poland
/
Healthcare
/
Synektik Spólka Akcyjna
SNT
Synektik Spólka Akcyjna
Cardiac marker could be a hit
PH
Phetuvov
Invested
Community Contributor
Published
13 Oct 24
Updated
15 Oct 24
7
Set Fair Value
1
votes
Share
Phetuvov
's Fair Value
zł204.19
10.5% overvalued
intrinsic discount
15 Oct
zł225.60
1Y
57.3%
7D
3.5%
Loading
1Y
57.3%
7D
3.5%
Author's Valuation
zł204.2
10.5% overvalued
intrinsic discount
Phetuvov's Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
Phetuvov
's
Fair Value
zł204.2
10.5% overvalued
intrinsic discount
Future estimation in
5 Years
time period
Past
Future
-359k
930m
2013
2016
2019
2022
2024
2025
2028
2029
Revenue zł929.8m
Earnings zł120.9m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
7.34%
Healthtech revenue growth rate
4.32%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
10.27%
Calculation
zł120.88m
Earnings '29
x
22.00x
PE Ratio '29
=
zł2.66b
Market Cap '29
zł2.66b
Market Cap '29
/
8.53m
No. shares '29
=
zł311.79
Share Price '29
zł311.79
Share Price '29
Discounted to 2024 @ 8.83% p.a.
=
zł204.20
Fair Value '24
